Navigation Links
CMS Approves Press Ganey as a Qualified Home Health Care CAHPS Survey Vendor
Date:9/30/2009

important part of the United States health care system, with as many as eight million Americans receiving this kind of care each year.(i) The CMS will use the HH-CAHPS survey to better evaluate and understand the quality of care provided by home health care agencies. Through Medicare and Medicaid, CMS covers more than 60 percent of the expense of home health care in the United States.(ii)

The voluntary HH-CAHPS participation time period is from October to December 2009. Another option is for an agency to begin with the "dry run" period between January and March 2010. Agencies must complete a dry run or participate in the voluntary implementation to be eligible for national implementation. The proposed CMS rule requires agencies to participate in the April 2010 national implementation to be eligible for their full annual payment update.

Press Ganey Associates, Inc.

For more than 20 years, Press Ganey has been committed to providing insight that allows health care organizations to improve the quality of care they provide while improving their bottom-line results. The company offers the largest comparative customer feedback databases, actionable data, solution resources, and unparalleled consulting and customer service. Press Ganey currently partners with more than 7,000 health care facilities--including more than 40% of U.S. hospitals--to measure and improve the quality of their care.

(i) Sangl J, Saliba D, Gifford DR, Hittle DF. Challenges in measuring nursing home and home health quality: lessons from the First National Healthcare Quality Report. Med Care. 2005 Mar;43(3 Suppl):I24-32.

(ii) Centers for Medicare & Medicaid Services, National Health Expenditure Data. Table 4: National Health Expenditures by Source of Funds and Type of Expenditure, Calendar Years 2002-2007. Available at http://www.cms.hhs.gov/Natio
'/>"/>

SOURCE Press Ganey
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves PRE-PEN Penicillin Allergy Test
2. FDA Approves Donor Screening Test for Antibodies to HIV
3. ClearWay Minnesota(SM) Board Approves New Officers
4. FDA Approves Vaccines for 2009 H1N1 Influenza Virus
5. FDA Approves 4 Swine Flu Vaccines
6. FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
7. FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
8. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
9. First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Programs Viability
10. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
11. FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...tients and survivors treated with chemotherapy suf...chronic conditions, hindering patients, ability to...versity of Rochester Medical Center. , A study o...p troubles at nearly three times the rate of the g...in younger patients and those with lung and breast...
(Date:11/23/2009)...ing chemo deal with insomnia, study shows , ... and sleep disorders affect more than three-quarte...ate nearly three times higher than that of the gen...em is more common in younger patients and in those...Rochester Medical Center researchers, who assessed...
(Date:11/23/2009)...23/PRNewswire/--Hazelden,theinternationallyrenowne...heleadershipteamforitsnewrecoverycenterinNaples,Fl...oopeninlateMarch2010,andwillinitiallyprovideaddict...ffamilyandoutpatientservices. ,, MichaelDemask,...lityinNaples,withBrendaIliff,M.A.,L.A.D.C.,asclini...
(Date:11/23/2009)...ewswire-USNewswire/-- The AmericanLegislativeExch...bershipassociationofstatelegislators,congratulates...ilinga constitutionalamendment toprotecttherightof...rolinanowbecomesthe24thstatewherelegislatorshavein...EC,s FreedomofChoiceinHealthCareAct . ,, (Logo:...
(Date:11/23/2009)...or Science Writings at Stevens Institute of Techno...y Robert Wright, journalist and founder, Bloggingh...m. at the Babbio Center for Technology Management,...c and the media., In his new book "The Evolution..., renowned for his popular works on evolutionary p...
Breaking Medicine News(10 mins):Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2
...entered the antismoking segment with its "Smoquit"...in Smoquit has been used for over a decade as an a... 13.50-per tablet priced Smoquit, the first pharma...ce. // Smoking causes or predisposes a perso...
...ssive smoking has a lasting impact on the respirat...National Center for Environmental Health in Atlant...ars. The researchers analysed the children's...d that passive smoking had the strongest impact on...
...enes more than 30 per cent higher. At around 30,00... sequence seemed scanty compared with the mustard ...el Cooke and colleagues at the Genomics Institute ...earchers detect the activity of some of the genes ...
...nding researchers who have pioneered a new drug, k...d supply directly. It represents a new approa...sels that feed a tumour, as well as activating the... to leak and break down. Due to restriction of its...
...iac arrest and are easier to use. Nearly quarter ...ear in the United States.// Many lives could be sa..., using an automated electrical defibrillator (AED...n staff to use them. But most cardiac arrest...
...r antioxidant effects than orange juice. according...food. The study states that, people who are ...ough increased antioxidant consumption might prefe...hor of the study. "In our tests, we saw dramatical...
Other Medicine News:
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...-AGlobalMarketReview ,, http://www.reportlin...bal-Market-Review.html#utm_source=prnewswire&u... Cardiovascularmonitoringisextremelybeneficialforc...lymonitoredduringdiagnosticaswellaspatientcarestag...
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...WorldMarketReview ,, http://www.reportlinker...ket-Review.html#utm_source=prnewswire&utm_medi...generalanesthesiadisposablesmarketischaracterizedb...ewitnessedingeneralsurgicalprocedures,growingpopul...
(Date:11/23/2009)...RNewswire-USNewswire/--JubilantOrganosys,theUniver...Institutetodayannouncedajointventurethatwillfocuso...hnologiesintheareasofOncology,MetabolicDiseaseandI...ndleveragedpartnershipthatwillacceleratethedevelop...orandumofUnderstandingwassignedtodayinWashington,D...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Link found between common sexual infection and risk of aggressive prostate cancer 56681 1Link found between common sexual infection and risk of aggressive prostate cancer 56681 2UAB researchers looking for genetic predictors for suicide 9855 1UAB researchers looking for genetic predictors for suicide 9855 2Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 1Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 2
...gies, Inc. (Nasdaq: RMTI ), a leading, innovative...ecialty pharmaceuticals focused on the end-,stage-...it has begun dosing,patients in its Phase IIb Dose...sphate (SFP), the Company,s physiological iron-mai...ign is a double-blind, multi-center,randomized, pl...
...als,Inc., a privately-held biopharmaceutical compa...hronic and acute inflammatory diseases,announced t...ng in its,Phase II clinical study of its lead comp...ta analysis is scheduled to be completed by the en...ollment of this study and look,forward to reportin...
Other Medicine Technology:Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 2Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 3Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 4Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 2Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 3
Thermal Seal, Clear
Mylar Plate Sealers
OptiTape Roll with dispenser. 250 pk.
Eppendorf Heat Sealing Film
Medicine Products: